Circulating osteocalcin as a bone-derived hormone is inversely correlated with body fat in patients with type 1 diabetes

PLoS One. 2019 May 3;14(5):e0216416. doi: 10.1371/journal.pone.0216416. eCollection 2019.

Abstract

The objective of the present study was to investigate the correlations between serum undercarboxylated osteocalcin (ucOC) or osteocalcin (OC) concentrations and %body fat, serum adiponectin and free-testosterone concentration, muscle strength and dose of exogenous insulin in patients with type 1 diabetes. We recruited 73 Japanese young adult patients with childhood-onset type 1 diabetes. All participants were receiving insulin replacement therapy. The correlations between logarithmic serum ucOC or OC concentrations and each parameter were examined. Serum ucOC and OC concentrations were inversely correlated with %body fat (r = -0.319, P = 0.007; r = -0.321, P = 0.006, respectively). Furthermore, multiple linear regression analyses were performed to determine whether or not serum ucOC or OC concentrations were factors associated with %body fat. Serum ucOC and OC concentrations remained significant factors even after adjusting for gender, HbA1c, body weight-adjusted total daily dose of insulin and duration of diabetes (β = -0.260, P = 0.027; β = -0.254, P = 0.031, respectively). However, serum ucOC and OC concentrations were not correlated with serum adiponectin or free-testosterone concentrations, muscle strength or dose of exogenous insulin. In conclusion, our study demonstrates the inverse correlation between serum ucOC or OC concentrations and body fat in patients with type 1 diabetes.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adiponectin / blood
  • Adiposity*
  • Adult
  • Diabetes Mellitus, Type 1 / blood*
  • Diabetes Mellitus, Type 1 / drug therapy
  • Female
  • Humans
  • Insulin / administration & dosage
  • Male
  • Osteocalcin / blood*
  • Testosterone / blood

Substances

  • ADIPOQ protein, human
  • Adiponectin
  • BGLAP protein, human
  • Insulin
  • Osteocalcin
  • Testosterone

Grants and funding

M.M. received the grant from Japan Agency for Medical Research and Development (No. 17lk1010002h0003) (https://www.amed.go.jp/en/index.html). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.